I

Inner Mongolia Furui Medical Science Co Ltd
SZSE:300049

Watchlist Manager
Inner Mongolia Furui Medical Science Co Ltd
SZSE:300049
Watchlist
Price: 67.9 CNY -2.6% Market Closed
Market Cap: ¥18B

Operating Margin

22.2%
Current
Improving
by 1.1%
vs 3-y average of 21.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
22.2%
=
Operating Income
¥326.9m
/
Revenue
¥1.5B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
22.2%
=
Operating Income
¥326.9m
/
Revenue
¥1.5B

Peer Comparison

Country Company Market Cap Operating
Margin
CN
Inner Mongolia Furui Medical Science Co Ltd
SZSE:300049
18.1B CNY
Loading...
US
Eli Lilly and Co
NYSE:LLY
969.6B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.3B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.1B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
271.3B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
148.3B USD
Loading...
FR
Sanofi SA
PAR:SAN
93.8B EUR
Loading...

Market Distribution

Higher than 88% of companies in China
Percentile
88th
Based on 8 544 companies
88th percentile
22.2%
Low
-409 046.1% — -1.4%
Typical Range
-1.4% — 10.3%
High
10.3% — 876.4%
Distribution Statistics
China
Min -409 046.1%
30th Percentile -1.4%
Median 4.2%
70th Percentile 10.3%
Max 876.4%

Inner Mongolia Furui Medical Science Co Ltd
Glance View

Market Cap
18B CNY
Industry
Pharmaceuticals

In the vast expanse of the healthcare landscape, Inner Mongolia Furui Medical Science Co., Ltd. has carved its niche by melding traditional Chinese medical wisdom with contemporary scientific advancements. Founded in the milieu of China's rich cultural heritage in Inner Mongolia, the company has emerged as a pivotal player in the pharmaceutical and biotechnology sectors. It specializes in the research, development, production, and sale of heparin products. Heparin, an anticoagulant drug crucial in preventing and treating blood clots, has been the cornerstone of Furui Medical's success, establishing them as a key supplier in both domestic and international markets. By leveraging China's comprehensive supply chain and stringent quality control measures, Furui has ensured its products meet the demanding standards of healthcare providers worldwide. At the heart of Furui Medical's business model is a well-oiled system that not only focuses on enhancing product efficacy but also strives for innovation in its production processes. The company has invested significantly in building state-of-the-art manufacturing facilities and a robust R&D department, which allow it to maintain a competitive edge in the biopharmaceutical domain. This focus on technological enhancement and adherence to international quality standards facilitates Furui Medical's penetration into global markets, particularly in Europe and North America. Additionally, their strategic partnerships and expansive distribution networks help them capitalize on emerging opportunities in the global anticoagulant market. Through this blend of tradition and modernity, Furui Medical not only contributes to the healing arts but also ensures sustainable business growth.

Intrinsic Value
38.49 CNY
Overvaluation 43%
Intrinsic Value
Price
I
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
22.2%
=
Operating Income
¥326.9m
/
Revenue
¥1.5B
What is Inner Mongolia Furui Medical Science Co Ltd's current Operating Margin?

The current Operating Margin for Inner Mongolia Furui Medical Science Co Ltd is 22.2%, which is above its 3-year median of 21.1%.

How has Operating Margin changed over time?

Over the last 3 years, Inner Mongolia Furui Medical Science Co Ltd’s Operating Margin has increased from 16.8% to 22.2%. During this period, it reached a low of 16.8% on Sep 30, 2022 and a high of 24.1% on Mar 31, 2024.

Back to Top